Giacinto Bagetta Selected Research

Lipid Nanoparticles

1/2022

Requirements for Translation in Clinical Trials of Aromatherapy: The Case of the Essential Oil of Bergamot (BEO) for Management of Agitation in Severe Dementia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giacinto Bagetta Research Topics

Disease

28	Pain (Aches) 05/2024 - 01/2009
16	Ischemia 01/2017 - 09/2004
14	Stroke (Strokes) 03/2023 - 08/2005
13	Glaucoma 05/2023 - 01/2008
13	Brain Ischemia (Cerebral Ischemia) 03/2023 - 09/2004
11	Dementia (Dementias) 08/2022 - 01/2017
9	Ischemic Stroke 03/2023 - 01/2007
9	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 03/2023 - 09/2007
9	Neuralgia (Stump Neuralgia) 08/2022 - 01/2009
9	Hyperalgesia 01/2022 - 01/2009
8	Migraine Disorders (Migraine) 12/2023 - 01/2019
8	Brain Injuries (Brain Injury) 11/2022 - 01/2009
6	Neoplasms (Cancer) 04/2023 - 09/2013
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2008
5	Reperfusion Injury 01/2021 - 02/2010
4	Brain Infarction 11/2022 - 12/2015
4	Chronic Pain 08/2022 - 04/2017
4	Mood Disorders (Mood Disorder) 01/2022 - 09/2010
4	Neuroblastoma 02/2018 - 09/2002
3	Inflammation (Inflammations) 05/2024 - 01/2015
3	Cognitive Dysfunction 01/2024 - 01/2019
3	Cancer Pain 04/2023 - 09/2010
3	Nervous System Diseases (Neurological Disorders) 01/2021 - 08/2005
3	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 08/2005
3	Infarction (Infarctions) 01/2016 - 09/2007
2	Anxiety Disorders (Anxiety Disorder) 04/2024 - 01/2019
2	Necrosis 03/2023 - 09/2002
2	Headache (Headaches) 01/2022 - 01/2022
2	Hypersensitivity (Allergy) 02/2015 - 02/2013
2	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 01/2008 - 10/2005
2	Seizures (Absence Seizure) 03/2004 - 02/2002
1	Amnesia (Dissociative Amnesia) 09/2023
1	Transient Global Amnesia 09/2023
1	Memory Disorders (Memory Loss) 09/2023
1	Ocular Hypertension (Glaucoma, Suspect) 05/2023
1	Neuroinflammatory Diseases 01/2023
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 04/2022

Drug/Important Bio-Agent (IBA)

19	Volatile Oils (Essential Oils)IBA 04/2023 - 01/2009
11	Retinaldehyde (Retinal)IBA 01/2020 - 10/2005
10	Glutamic Acid (Glutamate)FDA Link 04/2024 - 03/2004
9	Proteins (Proteins, Gene)FDA Link 03/2023 - 02/2002
9	Analgesics (Analgesic Drugs)IBA 08/2022 - 09/2013
8	Neuroprotective AgentsIBA 05/2023 - 08/2005
6	Calcitonin Gene-Related PeptideIBA 11/2022 - 01/2019
6	Opioid Analgesics (Opioids)IBA 02/2021 - 04/2017
6	Azithromycin (Zithromax)FDA LinkGeneric 01/2019 - 01/2016
5	mesoglycanIBA 01/2024 - 01/2020
5	Antipsychotic Agents (Antipsychotics)IBA 08/2022 - 02/2021
5	Monoclonal AntibodiesIBA 01/2022 - 01/2019
5	linaloolIBA 09/2013 - 01/2009
4	Neurotransmitter Agents (Neurotransmitter)IBA 12/2023 - 05/2012
4	EndocannabinoidsIBA 01/2009 - 07/2007
3	CalciumIBA 01/2022 - 01/2018
3	Tryptamines (Triptans)IBA 09/2021 - 01/2019
3	Gabapentin (Neurontin)FDA LinkGeneric 02/2021 - 01/2020
3	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 01/2011
3	LimoneneIBA 02/2018 - 09/2013
3	Anti-Bacterial Agents (Antibiotics)IBA 11/2016 - 01/2016
3	MacrolidesIBA 11/2016 - 01/2016
3	CytokinesIBA 01/2016 - 02/2010
3	CannabinoidsIBA 01/2008 - 07/2007
2	Type A Botulinum Toxins (Botox)FDA Link 12/2023 - 01/2022
2	2-pentadecyl-2-oxazolineIBA 09/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2014
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 01/2015
2	AntioxidantsIBA 11/2022 - 01/2020
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 06/2022 - 01/2009
2	eptinezumabIBA 09/2021 - 01/2019
2	5-MethoxypsoralenIBA 03/2021 - 09/2013
2	Antidepressive Agents (Antidepressants)IBA 02/2021 - 01/2019
2	Formaldehyde (Formol)FDA Link 01/2020 - 05/2012
2	Anticonvulsants (Antiepileptic Drugs)IBA 09/2018 - 01/2009
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 09/2018 - 02/2002
2	Sirolimus (Rapamycin)FDA Link 01/2018 - 01/2014
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2017 - 01/2007
2	EnzymesIBA 11/2016 - 01/2016
2	Bexarotene (LGD1069)FDA Link 02/2016 - 12/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 01/2009
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2012 - 02/2011
2	Estrogens (Estrogen)FDA Link 09/2007 - 08/2005
2	anandamide (arachidonylethanolamide)IBA 09/2007 - 07/2007
1	LuciferasesIBA 05/2024
1	hericenone CIBA 05/2024
1	LipopolysaccharidesIBA 05/2024
1	NeuropeptidesIBA 12/2023
1	Scopolamine (Hyoscine)FDA Link 09/2023
1	Biogenic Amines (Biogenic Amine)IBA 09/2023
1	ColforsinIBA 05/2023
1	VitaminsIBA 05/2023
1	tramiprosateIBA 05/2023
1	Vitamin B Complex (B Vitamins)IBA 05/2023
1	Carrier Proteins (Binding Protein)IBA 03/2023
1	Messenger RNA (mRNA)IBA 03/2023
1	Sunflower OilIBA 11/2022
1	palmidrolIBA 08/2022

Therapy/Procedure

20	Therapeutics 05/2023 - 01/2008
10	Aromatherapy 04/2023 - 09/2010
7	Ligation 09/2021 - 01/2009
2	Pain Management 02/2022 - 04/2017
1	Integrative Oncology 04/2023